Clinical Trial Update: Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05233)(COMPLETED) [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2/3 trial evaluating the efficacy and long-term safety of a ragweed pollen sublingual tablet in adults with ragweed-induced rhinoconjunctivitis,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Allergic Rhinitis
• Asthma

Drugs mentioned

• Ragwitek (ragweed pollen extract sublingual tablet)

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Rhinitis; Allergic, With Asthma, Conjunctivitis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-07-14